This is a working overview of Aspartimide, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-24. Anything still debated is marked as such rather than presented as settled.
Because epitalon has no pharmacopoeial monograph, quality assessment depends on supplier documentation and independent testing. Certificates of analysis typically report a purity figure from a single chromatographic run, a measured mass and sometimes an appearance description, but methods and acceptance criteria are not harmonised across vendors. Third-party laboratories can repeat identity and purity measurements, and mismatches between labelled and measured peptide content have been described for research peptides generally. What constitutes adequate identity confirmation for a molecule of this size stays an open question, since mass agreement alone does not separate closely related sequences.
Identity testing for epitalon relies on reversed-phase high-performance liquid chromatography for purity and mass spectrometry for mass confirmation. Because the sequence contains no tryptophan or tyrosine, ultraviolet detection at 280 nanometres is insensitive, so chromatographic methods usually monitor absorbance near 214 nanometres, where the peptide backbone absorbs. Electrospray ionisation or matrix-assisted laser desorption/ionisation then checks the intact mass against the expected value near 390 daltons. Peptide mapping or amino acid analysis after acid hydrolysis can supplement these measurements, although such confirmatory work is seldom reported on commercial certificates of analysis.
Discussions in the literature often conflate three distinct entities: the pineal extract epithalamin, the isolated tetrapeptide AEDG, and commercial preparations sold under similar names. Reviews citing older Russian-language studies sometimes omit detail on purity, route of administration and control groups, which makes cross-study comparison difficult. Researchers working with the compound generally note the need for independent replication, standardized enzyme assays, and clearer reporting of peptide identity. These caveats are relevant when weighing claims that appear in secondary sources rather than in primary reports.
（TG:@pojiaai）Epitalon is a synthetic linear tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. It emerged from work on epithalamin, a peptide fraction prepared from bovine pineal tissue, and was designed as a short, chemically defined analogue of that extract. Early publications came mainly from Russian laboratories studying pineal peptides and aging-related endpoints. The compound appears in the literature under several spellings, including epithalon and epithalone, which complicates systematic searching. Its small size makes solid-phase assembly and routine analytical characterization straightforward.
| Property | Value | Notes |
|---|---|---|
| Analytical method | Reversed-phase HPLC | Purity determination, typically 214 nm |
| Mass confirmation | ESI or MALDI mass spectrometry | Compared with mass near 390 Da |
| Common synonyms | Epitalon, epithalon, AEDG | Naming differs between suppliers |
| Storage temperature | −20 °C or lower | Lyophilised powder, kept desiccated |
| Solution stability | Limited in neutral aqueous buffer | Aspartimide and hydrolysis pathways |
Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.
Storage and handling follow conventional peptide practice. Lyophilized epitalon is typically kept refrigerated or frozen, protected from moisture and light, and allowed to equilibrate to room temperature before opening to avoid condensation. Once dissolved, aqueous solutions are usually stored cold and used within a short period, since dilute peptide solutions can support microbial growth and may slowly degrade. The absence of cysteine and methionine reduces, but does not eliminate, oxidation concerns during long-term storage.
Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.
Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.
Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.
The compound is generally described as a synthetic analogue of a fragment isolated from a pineal gland extract. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology introduced it during the 1980s and 1990s while studying short peptides from animal tissue. The original extract, called epithalamin, is a heterogeneous mixture, whereas epitalon is a single defined sequence. That distinction matters because findings reported for the extract are not automatically findings about the pure tetrapeptide, and claims about broader biological effects remain a separate question from the chemical identity described here.
Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.
No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.
The most frequently cited laboratory finding is that AEDG increased telomerase activity and extended telomere length in cultured human somatic cells. That work used fetal fibroblast strains and reported changes in enzyme activity alongside altered division counts. Replication by unrelated groups has been limited, and the published record is largely a single-laboratory series rather than a multi-centre programme. The result supports a hypothesis about peptide influence on gene expression in cell culture; it does not by itself establish an effect on telomere length in living animals or in people.
Epitalon is the common name for a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, usually abbreviated AEDG. All four residues are proteinogenic amino acids, and the free peptide has a calculated mass near 390 grams per mole. Because the chain is short and carries no modifications, it is assembled readily by solid-phase synthesis and is distributed mainly as a freeze-dried solid for laboratory work. Catalogue listings use the spellings epitalon, epithalone, and simply AEDG, and the three refer to the same sequence.
The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.
The technique of knocking down genes using RNAi therapeutics has demonstrated success in randomized controlled clinical studies. These medications are a growing class of siRNA-based drugs that decrease the expression of proteins encoded by certain genes. To date, five RNAi medications have been approved by regulatory authorities in the US and Europe: patisiran (2018), givosiran (2019), lumasiran (2020), inclisiran (2020 in Europe with anticipated US approval in 2021), and vutrisiran (2022). While all of the current regulatory body approved RNAi therapeutics focus on diseases that originate in the liver, additional medications under investigation target a host of disease areas including cardiovascular diseases, bleeding disorders, alcohol use disorders, cystic fibrosis, gout, carcinoma, and eye disorders. Patisiran is the first double stranded siRNA-based medication approved in 2018 and developed by Alnylam Pharmaceuticals. Patisiran uses the RNAi cascade to suppress the gene that codes for TTR (transthryetin). Mutations in this gene may cause the misfolding of a protein responsible for hereditary ATTR amyloidosis. To achieve therapeutic response, patisiran is encased by a lipid nanoparticle membrane that facilitates crossover into the cytoplasm. Once inside the cell, the siRNA begins processing by the enzyme Dicer. Patisiran is administered by a healthcare professional through an intravenous infusion with dosing based on body weight. Warnings and precautions include risk of infusion-related reactions and reduced vitamin A levels (serum).
== Methods == Prohibited methods include manipulation of blood components (e.g. autologous red blood cell transfer, "blood doping"), manipulation of samples, and gene doping. These are prohibited at all times.
== Track listing == "Piano Introduction" – 4:33 "Maiden Voyage" (Hancock) – 13:18 "Nefertiti" (Shorter) – 5:17 "Introduction of Players/Eye of the Hurricane" (Hancock) – 18:35 "Toys" (Hancock) – 14:00 "Introductions" – 1:47 "You'll Know When You Get There" (Hancock) – 7:00 "Hang Up Your Hang Ups" (Hancock, Jackson, Ragin) – 11:54 "Spider" (Hancock, Jackson, Ragin) – 10:12 Recorded live at the Newport Jazz Festival, New York City Center, New York City, Tuesday, June 29, 1976. Tracks 1–4 performed by V.S.O.P., Tracks 5–7 performed by Mwandishi, Tracks 8–9 performed by the Headhunters.
== See also == Animal testing on invertebrates Microbiome in the Drosophila gut Eating behavior in Insects (Measurement) Fruit flies in space Genetically modified insect Gynandromorphism JETLAG gene List of Drosophila databases Spätzle (gene) Time flies like an arrow; fruit flies like a banana Transgenesis Zebrafish – another widely-used model organism in scientific research Enhancer-FACS-seq
== Vendors == To list on a market, a vendor may have undergone an application process via referral, proof of reputation from another market or given a cash deposit to the market. Many vendors list their wares on multiple markets, ensuring they retain their reputation even should a single market place close. Grams (closed December 2017) had launched "InfoDesk" to allow central content and identity management for vendors as well as PGP key distribution. Meanwhile, individual law enforcement operations regularly investigate and arrest individual vendors and those purchasing significant quantities for personal use. A February 2016 report suggested that a quarter of all DNM purchases were for resale.
Sources: en.wikipedia.org
== Properties == The physical and chemical properties of magnetic nanoparticles largely depend on the synthesis method and chemical structure. In most cases, the particles range from 1 to 100 nm in size and may display superparamagnetism.
=== Severe intoxication === As of 2007 there is no known antidote or reversal agent for caffeine intoxication. Treatment of mild caffeine intoxication is directed toward symptom relief; severe intoxication may require peritoneal dialysis, hemodialysis, or hemofiltration. Intralipid infusion therapy is indicated in cases of imminent risk of cardiac arrest in order to scavenge the free serum caffeine.
Samoyed dogs are most often white, and can have a brown tint to their double-layer coat, which is naturally dirt-repellent. They have been used in expeditions in both Arctic and Antarctic regions, and have a friendly and agreeable disposition.
Apart from a detailed plotline and a few developers' screenshots, however, little information has been released about the game since 2005. Sparse updates have been published over the years at the company's official website and in a few specialized game magazines, and the final product is expected to be released via Steam. Drawing some comparisons to vaporware titles, Planet Half-Life announced (as a joke) on April 1, 2007 that They Hunger: Lost Souls had again been redesigned and was set for release as a Nintendo DS game. In November 2008, the developers of the Sven Co-op mod announced that they had been working with Black Widow Games to develop a co-op version of They Hunger, which was later released as an addon to be played in the mod in December 2008.
== Nutrition == Dried chia seeds contain 6% water, 42% carbohydrates (including a high content of dietary fiber), 16% protein, and 31% fat (table). In a reference amount of 100 grams (3.5 oz), chia seeds supply 486 calories and are a rich source (20% or more of the Daily Value, DV) of the B vitamins, thiamin and niacin (52% and 55% DV, respectively). They are also a moderate source of riboflavin (13% DV) and folate (12% DV). The seeds contain dense amounts of several dietary minerals, including calcium, iron, magnesium, manganese, phosphorus, and zinc (all more than 20% DV; table). Chia oil contains a high percentage of essential fatty acids (approximately 60%) and a low content of saturated fatty acids. The fats of chia seed oil are mainly unsaturated, with linoleic acid (17–26% of total fat) and α-linolenic acid (50–57%) as the major fatty acids (see table).
Sources: en.wikipedia.org
New fossil material of a colugo and ungulates, possibly including the first known upper dentition of Pakkokuhyus lahirii, is described from the Eocene Pondaung Formation (Myanmar) by Ducrocq et al. (2026). He et al. (2026) date the mammalian assemblage from the Relu Basin in the Tibetan Plateau (China) to 39.2–38.1 million years ago, and find that the presence of this assemblage in the studied area coincided with a seasonal rainfall regime, climatic conditions with similarities to Mediterranean-type climate, and expansion of high-elevation subtropical forests. Evidence of impact of both regional climate changes (mid-Eocene aridification of Central Asia) and global ones (Paleocene–Eocene thermal maximum and cooling during the Eocene-Oligocene transition) on changes of composition of Paleogene mammal assemblages from Central Asia is presented by Benevento et al. (2026). A study on the species richness and morphological diversity of mammals from assemblages from the John Day Formation (Oregon, United States) is published by Peng & Famoso (2026), who find evidence of stronger relationship of sampling at sites from the studied formation with recorded taxonomic diversity than with morphological diversity. Revision of the composition of the assemblages of Neogene terrestrial mammals from the Chesapeake Group (Maryland and Virginia, United States) is published by Eshelman et al. (2026), who interpret the studied faunas as indicative of presence of a combination of forest and grassland habitats, with a gradual shift towards more forested environments. Arias-Concha et al.
In the 1930s, the French enologist Jean Ribéreau-Gayon published papers stating the benefits of this bacterial transformation in wine. During the 1950s, advances in enzymatic analysis allowed enologists to better understand the chemical processes behind malolactic fermentation. Émile Peynaud furthered enology understanding of the process and soon cultured stock of beneficial lactic acid bacteria was available for winemakers to use.
=== Clipse Week with Genius === Clipse collaborated with lyrics website and media company Genius for a series named Clipse Week. It began with a Genius Verified video for "Chains & Whips" on July 11, 2025. Verified is a series in which artists explain their songs' lyrical meaning and inspiration. Malice spoke about his faith, his time away from Clipse, and what made him return; he also commented on the perception that Pusha T is too outspoken about industry peers, arguing that his brother's statements are actually mild: "I truly admire his restraint. People think he goes over the top and just with me knowing where all the bodies are buried, I admire his restraint." Pusha T revealed that the chorus was started by Williams when the duo was stuck during the writing process. On the same day, Malice wrote official annotations for each track on Let God Sort Em Out through his verified Genius account. A Genius Verified video for "Ace Trumpets" was released on July 14.
== Career == Shapiro is most famous for voicing the G-Man and Barney Calhoun in all of the characters' appearances in the Half-Life series. Other video games in which he is credited as "Mike Shapiro" are Blood II: The Chosen, Grand Theft Auto: Liberty City Stories and Torin's Passage. Shapiro has also voiced many radio and TV commercials. Shapiro is a director of television shows and theater productions, with some of his shows being shown on Strike.TV. In 2007, Shapiro co-directed a TV pilot, Family Values, starring Rob Riggle; the pilot was screened at the New York Television Festival. Shapiro has also acted in recurring roles in television shows, including as Dr. Isaac Haimes in Law & Order: Special Victims Unit in the 2024–2025 season.
=== Hair === As male-pattern hair loss is caused by androgens, particularly dihydrotestosterone, feminizing hormone therapy causes the rapid cessation and reversal of hair loss, though the degree of regrowth may vary. In many cases, the use of estrogens and antiandrogens have a more profound impact on hair loss compared to treatments used in men such as finasteride due to the greater suppression of dihydrotestosterone. Occasionally, hormones can also have effects on scalp hair texture, depending on various genetic factors. Antiandrogens affect existing facial hair only slightly; patients may see slower growth and some reduction in density and coverage. This reduction of density is due to the decreasing hair diameter and slower terminal growth rate. Effects on hair size and density were noticeable in the first four months following the start of hormone therapy, but later subsided, with measurements staying constant. In patients in their teens or early twenties, antiandrogens prevent new facial hair from developing if testosterone levels are within the normal female range. Body hair (on the chest, shoulders, back, abdomen, buttocks, thighs, tops of hands, and tops of feet) turns, over time, from terminal ("normal") hairs to tiny, blonde vellus hairs. Arm, perianal, and perineal hair is reduced but may not turn to vellus hair on the latter two regions (some cisgender women also have hair in these areas). Underarm hair changes slightly in texture and length, and pubic hair becomes more typically female in pattern. Lower leg hair becomes less dense.
Sources: en.wikipedia.org
The molecule lacks aromatic residues, so it absorbs weakly near 280 nanometres, the wavelength applied to many other peptides. The peptide bond absorbs strongly below 220 nanometres, making 214 nanometres a practical compromise. Gradient methods must therefore use mobile phases with low ultraviolet absorbance to keep the baseline clean.
Neutral and slightly basic aqueous conditions promote aspartimide formation at the aspartate-glycine step, often followed by deamidation. Elevated temperature and repeated freeze-thaw cycles accelerate the loss. Acidic solutions and dry lyophilised powder are comparatively stable over short periods.
No monograph exists in the United States Pharmacopeia or the European Pharmacopoeia, and no widely distributed certified reference standard is available. Purity and identity therefore rest on supplier methods that are not harmonised. This absence is the main reason reported purities are difficult to compare between sources.
It is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, often abbreviated AEDG. The molecule is linear and contains no modified residues, so it is fully described by its sequence.